Systemic inhibition of miR-451 increases fibrotic signaling and diminishes autophagic response to exacerbate renal damage in Tallyho/Jng mice
- 27 July 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 319 (3) , F476-F486
Abstract
MiRNAs provide fine tuning of gene expression via inhibition of translation. miR-451 has a modulatory role in cell cycling via downregulation of mechanistic target of rapamycin. We aimed to test whether chronic systemic inhibition of miR-451 would enhance renal fibrosis (associated with deranged autophagy). Adult TallyHo/Jng mice (obese insulin resistant) were randomized to two treatment groups to receive either miR-451 inhibition [via a locked nucleic acid construct] or a similar scrambled locked nucleic acid control for 8 wk. All mice were fed a high-fat diet (60% kcal from fat) ad libitum and humanely euthanized after 12 wk. Kidneys and blood were collected for analysis. Renal expression of miR-451 was sixfold lower in inhibitor-treated mice compared with control mice. miR-451 inhibition increased kidney weight and collagen and glycogen deposition. Blood chemistry revealed significantly higher Na+ and anion gap (relative metabolic acidosis) in inhibitor-treated mice. Western blot analysis and immunohistochemistry of the kidney revealed that the inhibitor increased markers of renal injury and fibrosis, e.g., kidney injury molecule 1, neutrophil gelatinase-associated lipocalin, transforming growth factor-β, 14-3-3 protein-ζ, mechanistic target of rapamycin, AMP-activated protein kinase-α, calcium-binding protein 39, matrix metallopeptidase-9, and the autophagy receptor sequestosome 1. In contrast, the inhibitor reduced the epithelial cell integrity marker collagen type IV and the autophagy markers microtubule-associated protein 1A/1B light chain 3B and beclin-1. Taken together, these results support a protective role for miR-451 in reducing renal fibrosis by enhancing autophagy in obese mice.Keywords
Funding Information
- HHS | National Institutes of Health (TL1R001431)
- American Diabetes Association (1-18-PMF-002)
- Georgetown University (internal)
- SGPGIMS (internal)
This publication has 55 references indexed in Scilit:
- 14-3-3 Proteins are Regulators of AutophagyCells, 2012
- Inhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic NephropathyJournal of the American Society of Nephrology, 2012
- The miR-144/451 locus is required for erythroid homeostasisJournal of Experimental Medicine, 2010
- MicroRNAs and Their Role in Progressive Kidney DiseasesClinical Journal of the American Society of Nephrology, 2009
- MicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cellsNucleic Acids Research, 2009
- MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney diseaseJournal of Clinical Investigation, 2008
- Podocyte-Specific Deletion of Dicer Alters Cytoskeletal Dynamics and Causes Glomerular DiseaseJournal of the American Society of Nephrology, 2008
- The E2F3-Oncomir-1 Axis Is Activated in Wilms' TumorCancer Research, 2008
- MicroRNA–target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysisGenome Research, 2008
- Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liverNucleic Acids Research, 2007